))
The Shortage of Stimulant Medications for ADHD - Why It's Still a Problem Today
Manage episode 435415553 series 3588182
Indhold leveret af Dr. Jenna Cheng, Dr. Patrick Kelly, Dr. Jenna Cheng, and Dr. Patrick Kelly. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Dr. Jenna Cheng, Dr. Patrick Kelly, Dr. Jenna Cheng, and Dr. Patrick Kelly eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
In this episode, we take a quick break from attachment theory and dive into a very real, current problem we face today: the stimulant medication shortage for the treatment of ADHD. We explore the complex regulatory systems surrounding stimulants, including supply chain issues and being lumped into the category of Schedule II medications monitored by the Drug Enforcement Agency (DEA) to fight the Opioid Epidemic. The pressures from many layers of control fall on the shoulders of the pharmacist, and worst of all, the patients. Lastly, we discuss how to mitigate this shortage issue for patients, and the need for patient advocacy amongst clinicians.
Have questions for us, or feedback about our podcast? Send us a message!
8 episoder
Del
